MajesTEC-1: Teclistamab in R/R MM Treatment

A look at BCMA targeting in relapsed/refractory multiple myeloma treatment and the BCMA-directed bispecific antibody teclistamab.

Related Videos
Expert on lung cancer
Expert on NSCLC
Expert on NSCLC
Expert on NSCLC
Related Content